PUBLICATION

The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress

Authors
Ebrahimie, E., Moussavi-Nik, S.H., Newman, M., Van Der Hoek, M., Lardelli, M.
ID
ZDB-PUB-160401-2
Date
2016
Source
Journal of Alzheimer's disease : JAD   52(2): 581-608 (Journal)
Registered Authors
Lardelli, Michael, Newman, Morgan
Keywords
Gene regulatory networks, neurodegenerative diseases, transcriptome profiling, zebrafish
MeSH Terms
  • Animals
  • Disease Models, Animal
  • Gene Expression Profiling
  • Gene Regulatory Networks
  • Hypoxia/genetics
  • Hypoxia/immunology*
  • Interleukin-1beta/metabolism
  • Microarray Analysis
  • Morpholinos
  • Oligonucleotides, Antisense
  • Presenilin-1/antagonists & inhibitors
  • Presenilin-1/genetics
  • Presenilin-1/metabolism*
  • Protein Isoforms
  • Real-Time Polymerase Chain Reaction
  • Receptors, CCR5/metabolism
  • Zebrafish
  • Zebrafish Proteins/metabolism
PubMed
27031468 Full text @ J. Alzheimers Dis.
Abstract
Dominant mutations in the PRESENILIN genes PSEN1 and PSEN2 cause familial Alzheimer's disease (fAD) that usually shows onset before 65 years of age. In contrast, genetic variation at the PSEN1 and PSEN2 loci does not appear to contribute to risk for the sporadic, late onset form of the disease (sAD), leading to doubts that these genes play a role in the majority of AD cases. However, a truncated isoform of PSEN2, PS2V, is upregulated in sAD brains and is induced by hypoxia and high cholesterol intake. PS2V can increase γ-secretase activity and suppress the unfolded protein response (UPR), but detailed analysis of its function has been hindered by lack of a suitable, genetically manipulable animal model since mice and rats lack this PRESENILIN isoform. We recently showed that zebrafish possess an isoform, PS1IV, that is cognate to human PS2V. Using an antisense morpholino oligonucleotide, we can block specifically the induction of PS1IV that normally occurs under hypoxia. Here, we exploit this ability to identify gene regulatory networks that are modulated by PS1IV. When PS1IV is absent under hypoxia-like conditions, we observe changes in expression of genes controlling inflammation (particularly sAD-associated IL1B and CCR5), vascular development, the UPR, protein synthesis, calcium homeostasis, catecholamine biosynthesis, TOR signaling, and cell proliferation. Our results imply an important role for PS2V in sAD as a component of a pathological mechanism that includes hypoxia/oxidative stress and support investigation of the role of PS2V in other diseases, including schizophrenia, when these are implicated in the pathology.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping